olfactory receptor family 8 subfamily B member 9 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR8B9P profile across patient tissues and cancer cell-line models. OR8B9P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, OR8B9P is differentially expressed in 2, with the highest sampling consensus in KIRP. Additionally, OR8B9P RNA expression shows 6,193 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ACC, KIRP, and STAD as cancer lineages where OR8B9P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR8B9P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR8B9P survival associations across molecular data types. OR8B9P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR8B9P RNA expression–survival associations across cancer types. High OR8B9P expression shows unfavorable associations in ACC, LUSC, GBM, LAML and LIHC, but favorable associations in KIRP. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for OR8B9P RNA expression.
This table summarizes OR8B9P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for OR8B9P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR8B9P shows higher tumor expression in KIRP and BRCA. The KIRP box plot shows higher OR8B9P RNA expression in tumor versus normal tissue (log2 FC = +0.014, t-test p = .033).
This table shows molecular features associated with OR8B9P in patient tissues and cancer cell lines. In patient samples, OR8B9P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
